A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients.

Trial Profile

A Randomized Placebo-Controlled Study of Perifosine in Combination With Single Agent Chemotherapy for Metastatic Cancer Patients.

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Mar 2013

At a glance

  • Drugs Capecitabine; Docetaxel; Doxorubicin; Gemcitabine; Irinotecan; Paclitaxel; Pemetrexed; Perifosine
  • Indications Advanced breast cancer; Colorectal cancer; Head and neck cancer; Non-small cell lung cancer; Ovarian cancer; Prostate cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Oct 2011 Final results in colorectal cancer patients published in the Journal of Clinical Oncology.
    • 02 Jun 2009 Interim results in colorectal cancer patients presented at the 45th Annual Meeting of the American Society of Clinical Oncology.
    • 07 Apr 2008 Status changed from recruiting to in progress, according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top